CHROMID? CANDIDA AGAR 43631

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2019-02-27 for CHROMID? CANDIDA AGAR 43631 manufactured by Biomerieux S.a..

Event Text Entries

[141220380] A customer in the (b)(6)contacted biom? Rieux to report the occurrence of little/no growth (false negative) for a candida albicans strain in association with the chromid? Candida media. The patient isolate was confirmed as candida albicans via maldi-tof test method. The customer stated that no incorrect result was reported to the treating physician, and that no patient harm or inappropriate treatment occurred. The customer indicated a delay of >24 hours to report a result due to additional testing required. The customer informed biom? Rieux that the chromid candida plates are routinely left in the lab on a rack for about five (5) hours during the day and the leftover plates are returned to the refrigerator. Per the chromid candida agar (can2) instructions for use....... This medium must not be exposed to light other than during the inoculation and reading steps. Allow reagents to come to room temperature in the dark. Inoculate the specimen. Immediately incubate the inverted plates in the dark at +37? C in aerobic conditions. The user is responsible for choosing the appropriate incubation temperature for the intended use, in accordance with current standards. The cultures are generally examined after 24, 48 hours of incubation, or even 72 hours depending on the type of specimen and the kind of microorganism being detected. The customer stated that, in spite of this instruction, the candida albicans ncpf 3255 growth control passed each day. The customer stated that the reported patient results were not affected by this issue. However the customer reported a delay of >24 hours between the time when the initial results should have been reported and the time when the repeat result was reported. There is no indication or report from the hospital or treating physician to biom? Rieux that the discrepant result led to any adverse event related to the patient's state of health. A biom? Rieux internal investigation will be initiated.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9615755-2019-00002
MDR Report Key8375662
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2019-02-27
Date of Report2019-03-01
Date Mfgr Received2019-02-28
Device Manufacturer Date2018-11-05
Date Added to Maude2019-02-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. JEFF SCANLAN
Manufacturer Street595 ANGLUM ROAD
Manufacturer CityHAZELWOOD MO 63042
Manufacturer CountryUS
Manufacturer Postal63042
Manufacturer Phone3147318694
Manufacturer G1BIOMERIEUX S.A.
Manufacturer Street5 RUE DES AQUEDUCS
Manufacturer CityCRAPONNE, 69290
Manufacturer CountryFR
Manufacturer Postal Code69290
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCHROMID? CANDIDA AGAR
Generic NameCHROMID? CANDIDA AGAR
Product CodeJSJ
Date Received2019-02-27
Catalog Number43631
Lot Number1006898250
Device Expiration Date2019-02-17
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBIOMERIEUX S.A.
Manufacturer Address5 RUE DES AQUEDUCS CRAPONNE, 69290 FR 69290


Patients

Patient NumberTreatmentOutcomeDate
10 2019-02-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.